An innovative project of Mount Sinai Medical Center in New York City, HepCure is improving provider knowledge & patient engagement for chronic disease management in persons infected with the Hepatitis C Virus (HCV). The toolkit is designed to address barriers for the effective care and treatment of HCV by providing web-based and smartphone enabled resources, navigation, consultation, and support for both patients and providers. The HepCure toolkit draws upon the experience of expert providers within the Mount Sinai Network, with support and development by Sinai AppLab, Mount Sinai Medical Center. HepCure was developed by the Mount Sinai Division of Liver Diseases, Division of General Internal Medicine, and the Informatics for Research, Outcomes, and Quality initiative in the Division of Gastroenterology.
HepCure is a secure, cloud-based provider portal meant to virtually navigate providers through hepatitis C virus (HCV) care. The HepCure dashboard integrates tools to more effectively manage HCV infected patients. A flexible, scalable platform, the HepCure Dashboard provides a seamless flow of information within a digital healthcare infrastructure. HepCure enables easy access to HCV resources and best-practices for optimal management of HCV patients with the opportunity to engage patients on treatment, while improving overall health outcomes. The platform serves as an organizational tool, with built-in workflow efficiencies that optimize treatment decisions, reduce redundancies, as well as promote provider training and development.
Through the use of the dashboard and patient app, providers can:
We at HepCure are always looking for ways to improve. That’s why we’re constantly working on new features and meeting new challenges! Here are just a few of the features we plan to explore:
The patient app is a free resource for patients with hepatitis C, which allows them to track medication adherence, symptoms, and gain access to resources. It is available to download for free on iOS (App Store) and Android (Google Play) operating systems. While the app can be used by patients independently from the dashboard, it can also be linked with the provider dashboard. Providers can push lab data to patients and track treatment adherence and symptom data input by patients in real time.
The HepCure Tele-Education Webinar Series features many diverse and salient topics in hepatitis C. Each week, the webinar series showcases different speakers who are prominent members of the hepatitis C community. Our webinars are attended by a wide audience, and include providers, patient navigators, and other health workers from around the globe. Our collaboration with the New York State Clinical Education Initiative (CEI) and Empire Liver Foundation (ELF) allows us to provide continuing education credits (CME/CNE) through attendance to our webinars on the first and last Tuesday of every month.
All webinars are held on Tuesdays from 4:30 - 5:30pm EST
Please join us on Tuesday, January 15th at 4:30 PM EST for a presentation by Dr. Pierre-Cedric Crouch and Pauli Gray of the San Francisco AIDS Foundation. Dr. Crouch and Mr. Gray will present on:
“TREAT FIRST – HCV Treatment and Care at Syringe Access Sites”
About Dr. Crouch:
Pierre is the Director of Nursing at Magnet, a community-based arm of the San Francisco AIDS Foundation that delivers sexual health services to gay, bi, and transmasculine communities in the San Francisco Bay Area. He grew up in New Orleans, Louisiana where he obtained his BSN from the Louisiana State University Health Science Center. He had an early passion for HIV care and technology, which lead him to move to San Francisco, where he received his MSN (Nurse Practitioner) and PhD from the University of California, San Francisco. He went on to develop and implement on of the largest nurse-led PrEP Health Program, which has garnered world-wide recognition. He geeks out over technologies that connect clients to their health and the development of RN-delivered community-based care. He leads in Health Care 3.0, which supports nurses practicing to the fullest extent of their license and taking a client-centered approach to remove traditional barriers to accessing health care. He is currently working on expanding anal health services, implementing full point of care STI testing, and developing a nurse-led community-based hepatitis C treatment program.
About Mr. Gray:
Pauli Gray has been doing Harm Reduction work with several specialties for 19 years, and Hep C work since 2002. Mr. Gray has done more than 600 Trainings and Speaking events on Hep C, OD Prevention, HIV, Needle Exchange and Harm Reduction, on three continents, from San Francisco to Africa. Besides being the Senior HCV Coordinator and Harm Reduction Specialist at the San Francisco AIDS Foundation for the Syringe Access Services program, Mr. Gray also is a member of the End Hep C Coordinating Committee, Treatment Access, Testing and Linkage Groups, and the Hep C Task Force.
On Tuesday, January 8th, Dr. Anthony Martinez of University at Buffalo presented on: Achieved SVR, What’s Next? HCV Post-Treatment Management
1. Define sustained virologic response (SVR).
2. Describe how to manage cirrhotic patients post-SVR
3. Discuss at-risk populations for HCV reinfection
Dr. Martinez cares for patients with liver disease, including viral hepatitis and alcoholic and fatty liver disease, in an outpatient setting at Erie County Medical Center and Evergreen Health Services where he serves as the Medical Director of both hepatology and Immunodeficiency. Utilizing a co-localization model of care, he treats patients with opiate dependency, HIV, HCV, and HIV-HCV co-infection and he is a Western Region Champion of the New York State Department of Health AIDS Institute Clinical Education Initiative.
– Grant/Research Support: AbbVie, Gilead, Merck, Tobira, Intercept
– Consultant: Gilead, Intercept, AbbVie, Bayer
– Speaker’s Bureau: AbbVie, Gilead, Bayer, Merck, Intercept
These learning modules are intended for clinicians of all backgrounds who may encounter or treat patients with hepatitis C and would like to establish core competencies in screening & diagnosis, evaluation and management of the disease. Content includes screening and linkage to care, initial evaluation, diagnosis and recognition of clinical manifestations. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
These learning modules are intended for clinicians who have experience treating patients with hepatitis C and would like to further their knowledge. These modules were originally presented as a component of the HepCure Tele-Education Webinar Series.
Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment
THe Psychosocial Readiness Evaluation and Preparation for Hepatitis C Treatment (PREP-C) is a free interactive online tool that enables you to provide a thorough assessment of a patient’s psychosocial readiness to begin Hepatitis C treatment, and make a treatment plan to improve treatment readiness.
This free online tool can be used by any type of professional involved in preparing a patient for Hepatitis C Treatment including medical providers, nurses, mental health, substance use, social work, pharmacy, case management, treatment adherence and health education specialists.